Galectin 3, a member of the galectin family, is increased in the left ventricle in the early post-ischemic period [10] that follows AMI and its serum levels are proven to correlate with the myocardial infarct size (quantified using cardiac magnetic resonance) [11] and with adverse ventricular remodeling and heart failure [7,12]. The gene discussed is LGALS3; the disease is myocardial infarction.